[The role of tumor necrosis factor in inflammation].
The paper presents up-to-date information about the action of the tumor necrosis factor in inflammatory pathology. It underlines the fact that a new category of medicines appeared: anti-TNF monoclonal antibodies which can offer new therapeutic perspective in the treatment of intraocular inflammation.
Muşat
O
O
CMDTA Acad St. Milcu.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D005128:Eye Diseases / Q000188:drug therapy; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha